Salesforce trails its tech large-cap peers and is the second-worst performer in the Dow this year, ahead of only UnitedHealth. The company's growth rate has been below 10% since mid-2024, and analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results